Farias, A., Soto, A., Puttur, F., Goldin, C. J., Sosa, S., Gil, C., . . . Berguer, P. M. (2021). A TLR4 agonist improves immune checkpoint blockade treatment by increasing the ratio of effector to regulatory cells within the tumor microenvironment. Nature Portfolio.
Cita Chicago Style (17a ed.)Farias, A., A. Soto, F. Puttur, C. J. Goldin, S. Sosa, C. Gil, F. A. Goldbaum, y P. M. Berguer. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.
Cita MLA (8a ed.)Farias, A., et al. A TLR4 Agonist Improves Immune Checkpoint Blockade Treatment by Increasing the Ratio of Effector to Regulatory Cells Within the Tumor Microenvironment. Nature Portfolio, 2021.